Baker McKenzie Switzerland played a pivotal role in advising Mateco group on its acquisition of Maltech Holding and subsidiaries, the prominent Swiss market leader in rentable lifting platforms. This acquisition marks a significant stride in the group’s expansive growth strategy, enhancing its foothold in key markets, notably Switzerland. Mateco, a major player in rentable working […]
In a strategic move to advance innovation in the Infection Control and Life Science domain, Metall Zug and Miele have inked a transformative agreement. The deal outlines the creation of a new joint venture, where
In a strategic move, Ringier has successfully acquired all shares in the former Swiss joint venture, Ringier Axel Springer Schweiz (RASCH), from Axel Springer. The joint venture, established in 2016, has been a collaborative effort until
Kohlberg Kravis Roberts (KKR) makes a significant investment into the Precipart Group, a renowned contract manufacturer of high-precision components to the medical, aerospace and industrial markets. KKR plans to support the company in its continued
The Danish company Kimbrer Computer, a supplier of used IT equipment and a Trill Impact portfolio company, has acquired Renewtech, a provider of circular IT services and networking solutions. The acquisition of Renewtech also marks
In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising EUR 67.5m (USD 72m) from a syndicate
LASCCO, a biomedical-technology company, and Abionic, a nanotechnology company, both based at the Biopôle of Lausanne, entered into a licensing agreement with Fapon Biotech, a global leading life sciences company, based in Dongguan (China)
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has acquired the 68.0% of the shares in Swiss pharmaceutical company Osmopharm and has disinvested the 76.4% in Egyptian pharmaceutical manufacturer SPIMACO Misr for Pharmaceutical Industries. The Transaction, with
Partners Group, a renowned global private markets firm, acting on behalf of its clients, has agreed to acquire ROSEN Group, a global provider of mission-critical inspection services for energy infrastructure assets, from its founder, Hermann